The absence of industry-wide pesticide testing standards leaves the emerging U.S. cannabis industry highly vulnerable to legal and health risks, but Neutra Corp. (NTRR) is offering a potential solution to the problem. The healthy lifestyle company is marketing a suite of horticultural products that can help control—and potentially eliminate—plant contaminates such as molds without the use of harsh chemicals in indoor cannabis grows.

Marijuana Business Magazine reported this month that a lack of industry-wide oversight has created a precarious situation in the cannabis industry, where growers, retailers and testers are often unclear on which pesticides and testing methodologies are proper and legal from region to region.

“While more and more cannabis testing facilities pop up around the country, there is no consistent, industry-wide guidance or enforcement on standards and methodology for pesticide testing in the nation’s fastest-growing industry,” said NTRR CEO Chris Brown. “We are working with producers who are eager for non-toxic solutions, instead.

“Fortunately, our company believes that we have an alternative,” he added.

Alongside its joint venture partner, Surface to Air Solutions (S2O2), NTRR is offering cannabis growers and other businesses new technologies designed to reduce or eliminate the industry’s reliance upon pesticides to produce healthy crops. The joint venture has a suite of horticultural products including a plant stimulant, an air-scrubber and self-cleaning hard surface treatment that has been carefully engineered to keep plants and surfaces clean and preventing the buildup of mold, powdery mildew, botrytis, and mites – allowing for healthy plants without the use of pesticides and fungicides.

NTRR completed a successful case study on its horticultural suite earlier this year in Colorado. The products are already in use in growing facilities in the U.S. and Canada.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), INSYS Therapeutics, Inc. (INSY) and ENDEXX Corp. (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com:https://www.businesswire.com/news/home/20150929005763/en/